File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Real-world effectiveness of nirmatrelvir–ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants

TitleReal-world effectiveness of nirmatrelvir–ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants
Authors
Wong, CKHLau, KTKLeung, GM
Issue Date1-Feb-2023
PublisherElsevier
Citation
The Lancet Infectious Diseases, 2023, v. 23, n. 6, p. 639-640 How to Cite?
DOI: http://dx.doi.org/10.1016/S1473-3099(23)00056-7
Persistent Identifierhttp://hdl.handle.net/10722/328377
ISSN
1473-3099
2023 Impact Factor: 36.4
2023 SCImago Journal Rankings: 6.329

 

DC FieldValueLanguage
dc.contributor.authorWong, CKH-
dc.contributor.authorLau, KTK-
dc.contributor.authorLeung, GM-
dc.date.accessioned2023-06-28T04:43:43Z-
dc.date.available2023-06-28T04:43:43Z-
dc.date.issued2023-02-01-
dc.identifier.citationThe Lancet Infectious Diseases, 2023, v. 23, n. 6, p. 639-640-
dc.identifier.issn1473-3099-
dc.identifier.urihttp://hdl.handle.net/10722/328377-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofThe Lancet Infectious Diseases-
dc.titleReal-world effectiveness of nirmatrelvir–ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants-
dc.typeArticle-
dc.identifier.doi10.1016/S1473-3099(23)00056-7-
dc.identifier.hkuros344658-
dc.identifier.volume23-
dc.identifier.issue6-
dc.identifier.spage639-
dc.identifier.epage640-
dc.identifier.eissn1474-4457-
dc.identifier.issnl1473-3099-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats